Bipolar Disorder Clinical Trials in New York

Showing 21-40 of 60 trials

Cornerstone Program for Transition-Age Youth Study Protocol for a Randomized Controlled Trial

NCT02696109

The purpose of this study is exploring a theoretically guided intervention, Cornerstone, which provides system 'boundary-spanning' services, including therapeutic services and mentorship, to transition-age youth with mental disorders. Cornerstone is designed to improve mental health service engagement and outcomes. The study uses a mixed methods approach to refine Cornerstone, and a hybrid design examining feasibility, acceptability, and preliminary impact with a randomized trial, alongside implementation.

DepressionStress Disorders, Post-traumaticBipolar Disorder

New York University59 participantsStarted Feb 2016

New York, New York, United States

TERMINATEDPHASE1< 1 mile

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

NCT02149823

Social cognition impairment is critical to the pathology and morbidity of a number of psychiatric disorders, including the schizophrenia spectrum, the autism spectrum and the personality disorders, thus representing a dimension consistent with RDoC. As such, this study aims to a) further characterize the unique deficits in social cognition (recognition and interpretation of social cues and representation of thoughts, intentions, and feelings of others) across disorders, including the schizophrenia spectrum (which includes schizophrenia, SCZ, schizoaffective disorder, SAD, bipolar disorder, BD, and schizotypal personality disorder, SPD), the autism spectrum disorders (ASD), and borderline personality disorder (BPD) compared to healthy controls (HC); b) assess the effect of intranasal oxytocin (OXT) as a regulator and novel treatment of social cognition impairment in these disorders; and c) enhance our understanding of the specificity and exact mechanisms of impairment to inform the accurate dosing of OXT required to modulate social cognition in these disorders and identify a model of optimum social cognitive function. Addressing these questions will further catalyze research into a model of optimum social cognitive activity, and accelerate industry development of agents suited to routine clinical administration.

Borderline Personality DisorderBPDSchizotypal Personality Disorder+5 more

Maria de las Mercedes Perez Rodriguez92 participantsStarted Sep 2013

New York, New York, United States • The Bronx, New York, United States

Cornerstone Program for Transition-Age Youth Study Protocol for a Randomized Controlled Trial

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

Bipolar Disorder Trials in Other Cities

NRX101 Glx Biomarker Validation Study

Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder

Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults

Pediatric Open-Label Extension Study

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Comparative Effectiveness Study for Bipolar Disorder

Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil

Tranylcypromine Treatment of Bipolar Depression

Bipolar Disorder Study for Men and Women

Minocycline for Bipolar Depression

Depression And Bipolar Disorder

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Emotion Recognition Modification for Bipolar Disorder

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Memantine and Cognitive Dysfunction in Bipolar Disorder

Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder

Other Conditions in New York